Deutsche Bank’s Rosetta Genomics ROSG Stock Holding History
Bought
Maintained
Sold
Other funds holding ROSG
HCM
Deutsche Bank's ROSG Position: Q4 2017 in Review
Deutsche Bank held its Rosetta Genomics (ROSG) position steady in Q4 2017 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5351.
Deutsche Bank first reported a position in ROSG in Q3 2017 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold ROSG as of Q4 2017.
- Deutsche Bank held 2 shares of Rosetta Genomics worth $0 as of Q4 2017.
- Deutsche Bank left its Rosetta Genomics share count unchanged in Q4 2017.
- Rosetta Genomics made up ﹤0.01% of Deutsche Bank's portfolio in Q4 2017, its #5351 holding.
- Deutsche Bank first reported a position in Rosetta Genomics in Q3 2017 and has held it in 2 quarters since.
- 10 funds tracked by Wall St. Rank held Rosetta Genomics as of Q4 2017.
Based on Deutsche Bank's 13F filing for Q4 2017, filed 14 Feb 2018.